Abacus Q2 Revenue Jumps 32% but Costs Surge, Squeezing Profits
ABX sits 90% above its 52-week low of $5.
Summary
Abacus Global Management delivered a 32% revenue increase to $132.4M for H1 2026, yet net income fell 37% to $13.9M as operating expenses surged 76%, led by a near-doubling of G&A costs. Cash reserves declined while debt remains high, though a new $75M credit line offers some relief.
Key Events · Earnings and Guidance · ABX
-
Revenue Growth Overshadowed by Cost Surge
Total revenue rose 32% YoY to $132.4M for H1 2026, but net income attributable to Abacus fell 37% to $13.9M as operating expenses jumped 76% to $77.2M.
-
G&A Expenses Nearly Double
General and administrative expenses surged 89% to $58.8M, driven by a $14.2M increase in legal and professional fees, raising concerns about cost control.
-
Valuation Methodology Change
The company adopted a Historical Return Method for valuing life settlement policies, replacing the prior discounted cash flow model, which could alter the pattern of reported gains.
-
Liquidity Tightens
Cash and equivalents fell to $23.4M from $38.1M at year-end, while total debt stands at $330.6M. A $75M credit facility amendment was signed but not yet funded as of June 30.
Analysis · ABX · Finance
A 32% revenue surge to $132.4M in the first half of 2026, powered by the Life Solutions segment, was undercut by a 76% jump in operating expenses that drove net income attributable to the company down 37% to $13.9M. General and administrative costs nearly doubled, reflecting a $14.2M spike in legal and professional fees. A shift in valuation methodology for life settlement policies could reshape the pattern of future reported gains. Meanwhile, cash reserves have dwindled to $23.4M against $330.6M in total debt, though a $75M credit facility amendment—signed but not yet funded—offers a potential liquidity bridge. The picture is one of robust top-line momentum overshadowed by escalating overhead and a tightening balance sheet.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.9% of the 1009 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ABX was trading at $9.52 on NYSE in the Finance sector, with a market capitalization of approximately $913.2M. The 52-week trading range was $5.00 to $12.44. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.